Last reviewed · How we verify
NCT02203812
The Effect of Probiotic Lozenge Administration on Gingivitis and on Mild & Moderate Periodontitis: A Randomized Controlled Clinical Trial.
Phase 3 trial testing Probiotic Arm in Mild and Moderate Chronic Periodontitis in 32 participants. Completed in 1 May 2016.
1 February 2016
Quick facts
| Lead sponsor | CD Pharma India Pvt. Ltd. |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 1 January 2015 |
| Primary completion | 1 February 2016 |
| Estimated completion | 1 May 2016 |
| Sites | 1 location across India |
Drugs / interventions tested
- Probiotic Arm — full drug profile →
- Placebo Arm
Conditions studied
- Mild and Moderate Chronic Periodontitis — all drugs for Mild and Moderate Chronic Periodontitis →
Sponsor
CD Pharma India Pvt. Ltd. — full company profile →
Who can join
Adults 20 to 50, any sex, with Mild and Moderate Chronic Periodontitis. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Improvement in Clinical Periodontal Indices
Time frame: 8 weeks
Improvement in clinical periodontal indices, namely, Plaque Index (PI), Gingival Index (GI), Probing Pocket Depth (PPD), Bleeding on Probing (BOP)
Sponsor's own description
The oral cavity is mostly influenced by general health. The oral microbiota which is as complex as the gastro-intestinal or vaginal microbiota are considered to be difficult therapeutic targets. The effects of probiotics in different fields of health care have resulted recently in the introduction of probiotics for oral healthcare. Probiotics have been clinically proved effective in different fields of oral healthcare such as halitosis, oral candidiasis and tooth decay. They have also been inducted in the field of periodontal healthcare because of the current views on the etiology of plaque- related periodontal inflammation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Recent advances in therapeutic probiotics: insights from human trials.
Cho M-Y, Eom J-H, Choi E-M, Yang S-J, et al · · 2025 · cited 17× · PMID 40261032 · DOI 10.1128/cmr.00240-24
Verify or expand the search:
- PubMed search for NCT02203812
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Probiotic Arm
Trials testing the same drug.
- NCT07253155 — Probiotics Use and Preventing Gastrointestinal Symptoms in People Living With Overweight and Obesity. · NA · enrolling by invitation
- NCT07504952 — Investigating the Impact of Probiotics on Wellbeing in a Community · NA · completed
- NCT06910397 — The Effect of Probiotics on Gums Health and Bad Breath · NA · completed
- NCT07520422 — Bacillus Coagulans Based Product in IBS-Diarrhea · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02203812 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CD Pharma India Pvt. Ltd.
- Last refreshed: 26 July 2016
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02203812.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing